We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-2.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$894M
AUM Growth
-$45.6M
Cap. Flow
-$16.9M
Cap. Flow %
-1.9%
Top 10 Hldgs %
46.04%
Holding
2,887
New
179
Increased
1,150
Reduced
723
Closed
200

Sector Composition

Rank Sector Weight
1 Financials 16.87%
2 Technology 14.74%
3 Healthcare 5.91%
4 Consumer Discretionary 3.51%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRIX icon
2026
Nurix Therapeutics
NRIX
$2.65B
$2.62K ﹤0.01%
333
+159
+91% +$1.45K
ACLS icon
2027
Axcelis
ACLS
$4.33B
$2.61K ﹤0.01%
16
+9
+129% +$1.58K
CUZ icon
2028
Cousins Properties
CUZ
$4.88B
$2.61K ﹤0.01%
128
-95
-43% -$2.17K
PHO icon
2029
Invesco Water Resources ETF
PHO
$2.09B
$2.61K ﹤0.01%
49
+48
+4,800% +$2.69K
CHE icon
2030
Chemed
CHE
$7.22B
$2.6K ﹤0.01%
5
-6
-55% -$3.12K
LNN icon
2031
Lindsay Corp
LNN
$1.18B
$2.59K ﹤0.01%
22
+4
+22% +$494
MOV icon
2032
Movado Group
MOV
$841M
$2.57K ﹤0.01%
94
-19
-17% -$517
STRA icon
2033
Strategic Education
STRA
$1.92B
$2.56K ﹤0.01%
34
WIRE
2034
DELISTED
Encore Wire Corp
WIRE
$2.55K ﹤0.01%
14
+1
+8% +$170
QTWO icon
2035
Q2 Holdings
QTWO
$3.92B
$2.55K ﹤0.01%
79
+6
+8% +$199
PCOR icon
2036
Procore
PCOR
$8.67B
$2.55K ﹤0.01%
39
+11
+39% +$735
BIPC icon
2037
Brookfield Infrastructure
BIPC
$4.85B
$2.54K ﹤0.01%
72
+65
+929% +$2.68K
FRT icon
2038
Federal Realty Investment Trust
FRT
$10.3B
$2.54K ﹤0.01%
28
+5
+22% +$493
PDSB icon
2039
PDS Biotechnology
PDSB
$43.4M
$2.52K ﹤0.01%
500
CAVA icon
2040
CAVA Group
CAVA
$7.27B
$2.51K ﹤0.01%
82
ESE icon
2041
ESCO Technologies
ESE
$7.92B
$2.51K ﹤0.01%
24
AVTA
2042
DELISTED
Avantax, Inc. Common Stock
AVTA
$2.51K ﹤0.01%
98
PACB icon
2043
Pacific Biosciences
PACB
$370M
$2.5K ﹤0.01%
300
-34
-10% -$389
PII icon
2044
Polaris
PII
$4.07B
$2.5K ﹤0.01%
24
+5
+26% +$594
PRG icon
2045
PROG Holdings
PRG
$1.71B
$2.49K ﹤0.01%
75
+16
+27% +$558
VKTX icon
2046
Viking Therapeutics
VKTX
$4B
$2.49K ﹤0.01%
225
+52
+30% +$744
AMPH icon
2047
Amphastar Pharmaceuticals
AMPH
$916M
$2.48K ﹤0.01%
54
REVG
2048
DELISTED
REV Group
REVG
$2.48K ﹤0.01%
155
NHI icon
2049
National Health Investors
NHI
$3.65B
$2.46K ﹤0.01%
48
-151
-76% -$7.9K
EEFT icon
2050
Euronet Worldwide
EEFT
$2.7B
$2.46K ﹤0.01%
31
-37
-54% -$3.44K

Similar funds

Lindbrook Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Lindbrook Capital held 2,887 positions worth $894M, down 4.8% from $939M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q3 2023 filing shows 179 new, 1,150 increased, 723 reduced and 200 closed positions. Its largest new stake was NuStar Energy L.P.: 17,923 shares worth $313K. The largest sale was Oaktree Specialty Lending, an estimated $7.4M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q3 2023 buy was NuStar Energy L.P.: 17,923 shares worth $313K.
  • Lindbrook Capital added most to Vanguard Morningstar Total Stock Market ETF in Q3 2023, an estimated $1.09M increase.
  • Lindbrook Capital's biggest Q3 2023 reduction was Oaktree Specialty Lending, cutting an estimated $7.4M.
  • Lindbrook Capital fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $912K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $894M portfolio in Q3 2023.
  • Lindbrook Capital opened 179 new positions and closed 200 in Q3 2023.
  • Lindbrook Capital's portfolio value fell 4.8% quarter-over-quarter to $894M.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.